Indeed, hyperglycemia, raised levels of insulin and insulin-like growth factor 1 (IGF1) display proliferative and oncogenic effects and they worsen the already existing cardiometabolic risk factors exasperating chronic inflammation, endothelial dysfunction, oxidative stress and DNA damage thus creating a favorable tumor microenvironment. Here, IGF1 is linked to endothelial dysfunction.